[Translation] A randomized, open-label, single-dose, two-formulation, two-sequence, two-period, cross-over controlled bioequivalence study of roxadustat capsules in healthy subjects under fasting and fed conditions
以湖南埃威格林医药科技有限公司提供的罗沙司他胶囊为受试制剂;并以珐博进(中国)医药技术开发有限公司的罗沙司他胶囊为参比制剂,进行人体相对生物利用度和生物等效性评价。
[Translation] Rosuvastatin capsules provided by Hunan Evergreen Pharmaceutical Technology Co., Ltd. were used as the test preparation, and rosuvastatin capsules produced by FibroGen (China) Pharmaceutical Technology Development Co., Ltd. were used as the reference preparation to evaluate the relative bioavailability and bioequivalence in humans.